Urinary liver-type fatty acid-binding protein levels for differential diagnosis of idiopathic focal glomerulosclerosis and minor glomerular abnormalities and effect of low-density lipoprotein apheresis

Clinical Nephrology

Volumn 65, Issue 1, 2006, Pages 1-6

  Nakamura, T ^a   Sugaya, T ^b   Kawagoe, Y ^a   Ueda, Y ^c   Osada, S ^d   Koide, H ^d  

^a Shinmatsudo Central General Hospital   (Japan)

^b RIKEN KOBE INSTITUTE   (Japan)

^c DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KOTO HOSPITAL   (Japan)

Author keywords

Fatty acid binding protein; Glomerulosclerosis; LDL apheresis; Tubular epithelial cell

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE; CREATININE; CYCLOPHOSPHAMIDE; FATTY ACID BINDING PROTEIN; LOW DENSITY LIPOPROTEIN; MIZORIBINE; PREDNISOLONE;

ADULT; APHERESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULOPATHY; HUMAN; KIDNEY BIOPSY; LABORATORY DIAGNOSIS; MALE; REGRESSION ANALYSIS; REMISSION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; URINALYSIS;

EID: 30744464579     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP65001     Document Type: Article

References (23)

1. Arici M, Chana R, Lewington A, Brown J, Brunskill NJ 2003 Stimulation of proximal tubular cell apoptosis by albumin-bound fatty acids mediated by peroxisome proliferator activated receptor-gamma. J Am Soc Nephrol 14: 17-27
2. Bonsib SM 1999 Focal-segmental glomerulosclerosis. The relationship between tubular atrophy and segmental sclerosis. Am J Clin Pathol 111: 343-348
3. Burgess E 1999 Management of focal segmental glomerulosclerosis: evidence-based recommendations. Kidney Int 55 (Suppl 70): S26-S32
4. Gordon BR, Kelsey SF, Dau PC, Gotto AM Jr, Graham K, Illingworth DR, Isaacsohn J, Jones PH, Leitman SF, Saal SD, Stein EA, Stem TN, Troendle A, Zwiener RJ 1998 Long-term effects of low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Liposorber Study Group. Am J Cardiol 81: 407-411
5. Hamilton JA, Era S, Bhamidipati SP, Reed RG 1991 Locations of the three primary binding sites for long-chain fatty acids on bovine serum albumin. Proc Natl Acad Sci USA 88: 2051-2054
6. Hattori M, Chikamoto H, Akioka Y, Nakakura H, Ogino D, Matsunaga A, Fukazawa A, Miyakawa S, Khono M, Kawaguchi H, Ito K 2003 A combined low-density lipoprotein apheresis and prednisone therapy for steroid-resistant primary focal segmental glomerulosclerosis in children. Am J Kidney Dis 42: 1121-1130
7. Humes HD, Nguyen VD, Cieslinski DA, Messana JM 1989 The role of free fatty acids in hypoxia-induced injury to renal proximal tubule cells. Am J Physiol 256: F688-F696
8. Kamijo Y, Kaneko Y, Ichikawa T, Kobayashi N, Koyama T, Kakegawa T, Kamijo H, Kono K, Minami S, Tanaka N, Arakura H, Hirata M, Higuchi M, Kiyosawa K, Hora K 2002 A case of nephrotic syndrome due to lupus nephritis which was controlled with low-density lipoprotein apheresis. Ther Apher 6: 459-462
9. Kamijo A, Kimura K, Sugaya T, Yamanouchi M, Hikawa A, Hirano N, Hirata Y, Goto A, Omata M 2004 Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease. J Lab Clin Med 143: 23-30
10. Kamijo A, Sugaya T, Hikawa A, Okada M, Okumura F, Yamanouchi M, Honda A, Okabe M, Fujino T, Hirata Y, Omata M, Kaneko R, Fujii H, Fukamizu A, Kimura K 2004 Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules. Am J Pathol 165: 1243-1255
11. Kearney JF, Radbruch A, Liesegang B, Rajewsky K 1979 A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J Immunol 123: 1548-1550
12. Kojima S, Harada-Shiba M, Toyota Y, Kimura G, Tsushima M, Kuramochi M, Sakata T, Uchida K, Yamamoto A, Omae T 1992 Changes in coagulation factors by passage through a dextran sulfate cellulose column during low-density lipoprotein apheresis. Int J Artif Organs 15: 185-190
13. Kriz W, Hosser A, Hahnel B, Gretz N, Provoost AP 1998 From segmental glomerulosclerosis to total nephron degeneration and interstitial fibrosis: a histopathological study in rat models and human glomerulopathies. Nephrol Dial Transplant 13: 2781-2798
14. Maatman RG, van de Westerlo EM, van Kuppevelt TH, Veerkamp JH 1992 Molecular identification of the liver- and the heart-type fatty acid-binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction. Biochem J 288: 285-290
15. Matthys E, Patel Y, Kreisberg J, Stewart JH, Venkatachalam M 1984 Lipid alterations induced by renal ischemia: pathogenic factor in membrane damage. Kidney Int 26: 153-161
16. Muso E, Mune M, Fujii Y, Imai E, Ueda N, Hatta K, Imada A, Takemura T, Miki S, Kuwahara T, Takamitsu Y, Tsubakihara Y, Kansai FGS LDL Apheresis Treatment (K-FLAT) Study Group 2001 Significantly rapid relief from steroid-resistant nephrotic syndrome by LDL apheresis compared with steroid monotherapy. Nephron 89: 408-415
17. Nagai K, Thogersen HC 1984 Generation of beta-globin by sequence-specific proteolysis of a hybrid protein produced in Escherichia coli. Nature 309: 810-812
18. Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Ebihara I, Koide H 2000 The urinary podocyte as a marker for the differential diagnosis of idiopathic focal glomerulosclerosis and minimal-change nephrotic syndrome. Am J Nephrol 20: 175-179
19. Nakamura T, Kawagoe Y, Ogawa H, Ueda Y, Hara M, Shimada N, Ebihara I, Koide H 2005 Effect of low-density lipoprotein apheresis on urinary protein and podocyte excretion in patients with nephrotic syndrome due to diabetic nephropathy. Am J Kidney Dis 45: 48-53
20. Pelsers MM, Hermens WT, Glatz JF 2005 Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta 352: 15-35
21. Remuzzi G, Bertani T 1998 Pathophysiology of progressive nephropathies. N Engl J Med 339: 1448-1456
22. Stenvinkel P, Alvestrand A, Angelin B, Eriksson M 2000 LDL-apheresis in patients with nephrotic syndrome: effects on serum albumin and urinary albumin excretion. Eur J Clin Invest 30: 866-870
23. Thompson GR 2003 LDL apheresis. Atherosclerosis 167: 1-13